MassChallenge is a non-equity startup accelerator headquartered in Boston, Massachusetts, with additional locations in Israel, Mexico, Switzerland, Texas, and the UK. Founded in 2009, it focuses on fostering innovation and entrepreneurship by supporting high-potential startups across various industries globally. MassChallenge provides expert mentorship, a tailored curriculum, and access to corporate partners without taking any equity from the startups. Its programs, including specialized initiatives like MassChallenge FinTech and MassChallenge HealthTech, aim to facilitate partnerships between startups and established companies to drive innovation and growth. To date, MassChallenge has helped over 1,200 alumni raise more than $2 billion in funding and create over 65,000 jobs, demonstrating its significant impact on the global innovation ecosystem.
Welfie provides health data assessments, insights, and resources to help people who care for kids make better health decisions. It is a school health platform helping k-12 schools deal with the health issues of their time.
Oculogenex is a biopharmaceutical company that specializes in gene therapy for the treatment of retinal disorders. The company was founded in 2020 and is headquartered in La Habra, California.
Wisedocs offers a machine-learning SaaS platform for insurance, legal, and independent medical evaluation firms to review medical records with ease. It was created to help the IME, diagnostics, medico-legal, and insurance industries organize and understand unstructured medical data. The company caters to the auto, liability, disability, workers' compensation, tort law, and similar markets. It offers an easy-to-integrate solution that enhances accuracy and speed to improve outcomes in processing medical records.
Carium is an app that helps people better manage their healthcare and wellness journeys. Carium's goal is to develop healthcare technology that supports the distinctive qualities, requirements, routines, and objectives of every individual along their individual health journey. Trusted care teams would be more prepared to make clinical decisions based on the best available evidence if they had access to augmented, actionable data gathered from everyday life. They have greatly surpassed that vision so far. Better results, a good return on investment, and more overall happiness are being experienced by care teams and the clients they serve.
Delfina provides a personalized prenatal care system that uses the power of data to keep moms and babies safe during pregnancy. Their data-driven approach is uncovering unique insights in prenatal care to pave the way for clinical innovation.
Together by Renee is a free app that uses generative AI to streamline and automate health tasks like ordering refills, booking appointments and completing forms in an easy user experience perfect for the 123 million aging Americans managing diabetes, obesity, hypertension, and more. Together measures vital signs like blood pressure via smartphone camera - with no devices or wearables required. Together requires no data entry, typing or integration to legacy systems, using just AI to automate patient-centric care coordination. 67% of Together’s first 15,000 users are over 55 years of age and Together enjoys NetPromoter score of +85.
Ferrum Health is a health technology company that provides AI-driven tools to improve patient outcomes and reduce medical errors. Its platform supports hospital systems by ensuring quality assurance in critical healthcare decisions throughout patient care. The company focuses on integrating AI to streamline processes and enhance the overall healthcare experience.
CBOH is a digital health platform that decentralizes control of health identity and data. It empowers users to control their digital health identity and share verifiable health statuses with whom they choose. It is on a mission to destigmatize health testing and eliminate the spread of transmissible infections.
HealthOpX provides software to community-based organizations, health systems, and payers to engage community members and improve their health. They can effectively carry out their own programs and work with government and health entities. They have a predictive analytics tool that enables them to assess the risk of a member's readmission, ER visit, and morbidity.
Oculogenex is a biopharmaceutical company that specializes in gene therapy for the treatment of retinal disorders. The company was founded in 2020 and is headquartered in La Habra, California.
Galileo Innovations
Non Equity Assistance in 2021
Galileo Innovations develops human performance-optimizing biotech gear and equipment for athletes, first responders, military members, and labor industry workers. Its proposed technology, KordoFan, augments users with actionable insights concerning environmental and biometric hazards in real-time to target heat injuries; through an array of biomimicry cooling designs, the device aids in speed, agility, mental clarity, muscle recovery, strength, and stamina during training/shifts.
INIA Biosciences utilizes the power of sound waves to develop non-invasive, home-administered, and closed-loop medical devices to manage chronic inflammatory diseases.
Condor powers smarter financial decisions in clinical development by combining financial intelligence, automation, and deep industry expertise. We help pharma and biotech companies optimize every dollar, streamline complex workflows, and accelerate the path to life-changing breakthroughs. Every dollar fuels innovation. Every decision drives impact. Every breakthrough happens faster.
Netnoids Rx Laboratories operates a cancer contract research organization that uses patient-derived organoid model systems to help find a cure for rare cancers.
Astellar Labs develops a non-invasive diagnostic technology that allows people to measure blood glucose without having to prick their fingers or wear a device that needs to be regularly swapped out, thus eliminating discomfort while also saving money.
Vaccine Systems expedites and simplifies vaccine preparation for caregivers and patients. Millions more people, particularly in the developing countries, can be immunized, saving tens of thousands of labor years through worldwide vaccination campaigns. Vaccine Systems creates equipment to help with this, resulting in increased access to vaccines, simplified preparation, and an essential margin of safety for those prepared at the point of care. At the same time, we reduce vaccine waste – which the WHO claims varies from 30% to 70% – and suboptimal vaccine re-allocation.
Analatom is an engineering company that offers hardware or software corrosion sensing and monitoring solutions for condition-based maintenance that includes aircraft, bridges, vehicles, heavy equipment, helicopters, pipelines, ships, and wind turbines. The company's contact modes are mail, phone, and physical address.
We founded AtomicAI to bring advances in computing and machine learning to nanomaterials manufacturing. We believe that nanomaterials will transform energy, electronics, and quantum technologies. But nanomaterials are really hard to make. We're here to help.
MediCircle utilizes technology to eliminate barriers to care and reduce pharmaceutical waste. The company collects leftover oral chemotherapeutics, ensures the medicine’s quality, and redistributes it to those in need. Its advanced technology allows them to offer a safe, low-cost alternative to disposal. MediCircle creates significant savings for patients, insurance companies, and healthcare facilities, all while improving the health of its local communities.
Mutuus is the first digital healthcare membership in Mexico, offering comprehensive end-to-end healthcare services through a user-friendly platform that includes free services, discounts, and full coverage to safeguard the health and wealth of our members.
Kismet Technologies delivers innovative material technologies for safe infection control on surfaces. It has developed a material technology (NanoRAD) that helps decrease how often people get sick by keeping surfaces pathogen-free long after NanoRAD has been applied to the surface.
Through the experience of 15-year skin optics research, we developed optical modules that work in conjunction with sophisicated algorithms to quantify various skin contents such as hemoglobin, bilirubin, skin collagen, skin oxidative stress, blood glucose variation, and etc. In contrast to the market available wearable optical modules that can only measure heart beat rate, our wearable module design provides much more information for personal health monitoring and thus could have multitude application scenarios with great marketing potential.
Delfina provides a personalized prenatal care system that uses the power of data to keep moms and babies safe during pregnancy. Their data-driven approach is uncovering unique insights in prenatal care to pave the way for clinical innovation.
Asan Therapeutics
Non Equity Assistance in 2021
Asan Therapeutics utilizes a novel technology that simplifies the treatment of cancer patients to receive only a single injection instead of several painful injections.
Yengii Biosciences develops the Galet smartphone microscope for detecting infectious illnesses such as malaria, sleeping sickness, and tuberculosis. The Galet platform is intended to do very complicated blood film analysis in a simple, portable point-of-care tool, which is now limited to high-end laboratories. Making such blood film analysis more available would allow for the early diagnosis of the most serious health concerns, such as malaria, and will save lives.
Histofi is a digital health platform in cancer care delivering AI-enabled diagnostic and treatment resources to providers worldwide; we use a SaaS platform with a local presence through Histofi Partner Providers (HPPs). We stand-out from others because of our ability to blend technologies and services through a user-friendly business model. The Histofi solution and sustainable business model ensure efficient scale-up to save more lives.
Stemloop—The Biosensor Company™—is on a mission to unlock the power of biology to sense and respond to the world's challenges. We discover, develop, and deploy novel technology to address unmet chemical sensing and detection needs with accessible and actionable cell-free biosensors that are faster, cheaper and easier than traditional laboratory testing.
Amira Health develops an app-based platform that tracks and addresses menopause symptoms with a suite of solutions. Its sensor bracelet tells how menopause is impacting the user's life, and its smart mattress pad can prevent hot flashes.
Lambent Data™ focuses on technology to engage families & individuals in managing their health & social determinants of health, in collaboration with healthcare & social service providers to improve outcomes & efficiencies. Employers can also support this process. We develop user-friendly, innovative software and powerful data analytics to tackle the needs of families, healthcare providers, and social service practitioners -- thus improving the health of children and adults while reducing healthcare costs.
Digi.Bio is accelerating the development of life saving cell therapies with a lab-on-a-chip and computational platform that analyzes how cell therapies perform and evaluate their outcome down to the single cell level, delivering high content results in 24 hours and with minimal material waste.
BioEclosion seeks to enhance user-friendly quantitative diagnostics to new molecular biomarkers for fast identification of emerging diseases that affect global health. The company started its activity with several patents, the most important being Celifast: a non-invasive approach for the detection of celiac disease. Addressing point of care attention of patients, the core technology has been successfully validated and the team is currently working on further development for commercialization.
FermBiotics is a microbiome company on a mission to improve gut health all over the world. FermBiotics produce sustainable, fermented plant ingredients for food.
We are a group of doctors and techies- a blend of experience and youth , a mixture of highly skilled sincere doctors and carefree youngsters who believe that nothing is impossible with technology.
React4life is an Italian biotech company founded in 2016 after more than 15 years of R&D by Silvia Scaglione and Maurizio Aiello, together with a multidisciplinary team of experts, with the ambition to turn the promise of biomedical research into concrete benefits for society. Scientists can finally rely on a new enabling technology to recapitulate human biology in the lab: MIVO® (Multi In Vitro Organ), the next generation of organ-on-a-chip. This cutting-edge microphysiological system enables researchers to overcome the limits of current in vitro assays and animal models. It improves the reliability and predictivity of several applications: pharmaceutical drug-testing, personalized medicine, novel immuno-oncology therapies, cosmetics, dermatology, and nutraceutical. Learn more at www.react4life.com
Biotic provides a circular, fully bio-based, fully biodegradable PHBV (PHA) polymer manufacturing process. Our polymer is applicable for the vast majority of today’s plastic demand including packaging, disposables, and single-use products. Enabling optimal transition from fossil-fuel-plastics, with a scalable, fully biological, environmentally friendly process, eliminating recycling needs, contributing towards reducing greenhouse gases emission, with a zero waste and circular economy approach.
Leucine Rich Bio is India's first and only Microbiome focused Genomics Based company. While, genomic approaches have gained huge clinical importance allowing us to align towards precision medicine, important uncertainties remain unanswered. The human microbiome, largely recognized as the "Second Genome", while rooted in the principles of genomics, have gained tremendous steam over the past few years. There is a heightened interest among researchers, clinicians and direct consumers in understanding the effects of the microbiome on health and wellness.
Michroma is a biotech platform that produces natural ingredients in a sustainable, scalable, and cost-effective way. It uses synthetic biology to unleash the potential of filamentous fungi and develop proprietary strains capable of producing high-performance ingredients in bioreactors. Our first products are extremely pH and thermal stable food colorants which we are prototyping with some of the top food & beverage and cosmetic companies in the world. We are also producing mycoprotein and many more ingredients to come. It accelerated by Indiebio (Batch 9) and we are part of Mista. Michroma is based in Rosario, Argentina and San Francisco, USA.
CRIAM offers rapid and accurate blood typing and infectious diseases detection anywhere, enabling prompt and well-informed clinical decision-making. Our stand-alone platform is portable and does not require electricity nor additional equipment or laboratory infrastructure, ensuring accessibility and usability in diverse settings. In addition, our solution is highly scalable: one reader can perform several types of tests using specific cartridges and computer vision algorithms suitable for detecting a wide range of infectious diseases, thus consolidating market penetration.
VenoVision is a contactless, AI-driven, cardiopulmonary monitoring platform. VenoVision helps reduce costly cardiac ICU admissions and improve patient stability at discharge by providing medical teams with continuous hemodynamic assessment. Insights previously limited to cardiac catheterizations can now be non-invasively captured by our contactless, thermal imaging monitoring device.
Tellus is a platform that provides actionable health information such as changes in vital signs or activity in real-time to improve eldercare quality and operational efficiency. Tellus uses advanced sensor technology to monitor health completely wirelessly, without the need for wearables. Tellus assists care facilities in understanding baseline health data, alerting them, and allowing them to make the best decisions for their residents during emergencies or to prevent them.
Digbi Health pioneered the use of Precsion Biology - genetics, gut microbiome, and CGM - to treat the top for food-related illnesses - Obesity, T2D, GI, and mental health. Its multi-condition platform allows employers to consolidate digital points solutions and allows polychronic patients to receive personalized care. It recently launched a nationwide virtual clinic to prescribe GLP drugs.
Qumata is building a new Standard for Life and Health Insurance Underwriting. We use digital data to calculate the risk of diagnosis for over 800 conditions, along with Extra Mortalities and Morbidities, saving applicants hours filling out long questionnaires or visiting the doctor. Find out more via www.qumata.com
MindMics is an emerging wearable company revolutionizing the information they can understand about the inner workings of our bodies and health. They hears every heartbeat to capture clinically meaningful biometrics accurately within real-time to unleash mental performance.
See Yourself Health provides immersive technology, data science, and social learning to accelerate and sustain health and wellness. They emphasize peer support, online learning, measurement-based care coaching, and chronic disease management health metaverse to optimize outcomes and speed up behavior change.
ZIbrio is a balance diagnostics company commercializing NASA technology originally used on astronauts upon return from space flight, dedicated to advancing novel biometrics for human balance. Zibrio seeks to empower users to take control of their health.
Limula provides a unique platform technology enabling scale out of cell therapy production. Our patent-granted solution is combining a bioreactor and a centrifuge into one device, for the first time. Our product is composed of hardware, software and consumables, allowing healthcare providers to safely manufacture CGT in a decentralised manner. By bringing manufacturing closer to the patients, our solution will broaden access to these highly personalised treatments.
myBiometry is developing a platform to monitor/manage patients with chronic disease using biomarker data from proprietary sensors and ML to identify patients at risk of treatment failure. Our initial focus is asthma where treatment failure occurs over 46% of the time (11.5M US patients, $80 billion). We are developing a single use, disposable sensor and device to track a biomarker of inflammation in breath. The data determines changes in adherence, treatment response, and risk of attack.
Starling Medical is developing a remote patient monitoring platform for at-home urine diagnostics that can be seamlessly integrated into anyone's bathroom routine. The objective of the organization is to develop predictive technology for the early detection of chronic health concerns.
Vigilant Software provides software solutions for drug drawing on demand. Their software automates several steps involved when hospital staff administer drugs drawn at the point of care in areas such as the operating room, post operative care, intensive care, and the emergency room.
TeVido will change the way reconstructive surgery is approached, starting by improving options for those who have lost skin color from scarring or disease. We will expand capability to others who suffer disfigurement and long to improve their self-esteem. In addition to reconstruction, TeVido technology will be applicable across a wide variety of needs for wound healing and cosmetic surgery.
CRG is a health care software company that makes a system called KBCore. KBCore is a patient-safety platform that uses predictive technology to cut costs and help doctors, nurses and staff better communicate. Developer of enterprise data management platform designed to allow healthcare organizations to develop better and safer patient care processes. The company delivers real-time clinical tools for rounds, meaningful insights for quality improvement and data capture to streamline risk management functions, enabling hospitals and other healthcare organizations in understanding patient safety data to identify active threats predicting and preventing harm.
StoreyLine is a movement to drive employee and client happiness through meaningful, mission-driven gifts & experiences, leading to higher retention and powerful recruitment strategies.
Byteflies is a Belgian-American wearable health company. Their team of medical experts, engineers, and data scientists is passionate about revolutionizing today's healthcare, one vital sign at a time. Their main office is in Antwerp (Belgium), closely located to major life sciences and clinical research centers. Their second office, located in the San Francisco Bay Area (California), operates in the heart of digital innovation.
Generus is a platform that hosts events and ongoing volunteer programs that address community and global needs and are built with positivity and employee satisfaction in mind.They connect companies, co-workers, and communities through virtual volunteering experiences.
Soma devices
Non Equity Assistance in 2020
Soma Devices offers a Train-of-Four (TOF) quantitative device that measures the level of neuromuscular blockade in patients during surgery. A novel approach to measure TOF requires the capture of limited movement of the thumb when the hands are strapped in suboptimal locations. The device includes a full glove, versatile to accommodate many hand sizes, and is easy to put on. Our vision is that anesthesiologists will be using the TOF device as part of routine checking to avoid postoperative issues.
Bloomsbury
Non Equity Assistance in 2020
Bloomsbury AI uses Artificial Intelligence and Big Data to identify new indications for existing drugs, reduce the time, cost, and risk in drug discovery.
MedFlyt is a provider of online staffing, orientation, clinical documentation, online training, remote onboarding, and compliance passport solutions. Their customers' inquiries are addressed through phone, email, and online applications.
Biomineral Systems specialises in environmental biochemical research, technology, and consulting services. They develop and distribute modelling and decision-support system tools from other vendors. They also environmental policy advisors to government agencies, and medium to large companies.
BINK Bio is working on developing biotech alternatives to reduce environmental damage. The company focuses on and technologies in the fields of biotech based dyes.
mk2 Biotechnologies uses a synthesis process to design, synthesize, and research peptides and proteins. Their process allows the scalable and production of purity peptides and proteins for a range of applications.
Vyasa Analytics provides a novel AI-powered platform for life sciences and healthcare organizations. The company allows businesses to integrate and analyze content across their entire data landscape. Vyasa Layar enables to connect to both cloud and on-premise data sources, resulting in a unified data platform that can be explored using a suite of low-code, deep learning applications. Each Layar instance connects to various data silos, whether cloud or on-premise, and regardless of file type.
Steradian Technologies is building a 30-second COVID-19 detection test. It uses focal point projection systems to recreate human eyesight and use photonics to detect pathogens in 30-seconds.
Grapheal is a Medtech startup, which produces embedded and wearable biosensors, digital by design, minimalistic in components, with capabilities to dose biomarkers and detect pathogens anywhere with a simple smartphone. Wireless electronic biosensors produced by Grapheal are based on graphene transistors which make field diagnostics and remote patient monitoring affordable & accurate.
Onexio Biosystems is a research and development company. They offer HTS screens that typically utilize a single reporter cell type that lacks important confounding biology, including drug metabolism and paracrine and endocrine cell interactions. Their microDUO supports co-culture and multi-culture to improve human relevance in drug discovery and chemical screening.
Hera - Mi is Specialized in digital medical imaging applied to breast cancer.Hera-MI has developed clinical decision support solutions to help improve early-stage breast cancer detection. Our solutions will improve the quality and accuracy of breast cancer diagnosis while decreasing radiologists’ interpretation time. Patients will be treated more quickly, offering them a better chance of remission. Hera-MI has developed Breast-SlimView, a clinical decision support software based on artificial intelligence and image processing for breast cancer diagnosis. Our partner, Fujifilm is selling Breast-SlimView in France and in the Overseas Territories of France (DROM/TOM). Breast-SlimView is also available for sale all over the world.
Karuna strives to help every patient access a guide in the healthcare system. Its integrated solution leverages infrastructure, workflow, and automation tools to form a single platform that copilots every interaction between patients, family members or other support, and the care team. The company was founded bin 2018 and is headquartered in San Francisco, California.
Tremedics develops bioresorbable technology for congenital heart disease patients with congenital heart disease need devices that resorb within their bodies as they grow. Their technology utilises a minimally invasive surgery procedure for stent delivery and permits vessel growth as the stent resorbs in the body.
Tembo Health is a telemedicine company serving retirement homes, senior care centers and skilled nursing facilities to connect patients with specialty services like psychiatry and cardiology. The platform connects the specialists to patient data and collaborates with the nursing staff to provide better care plans.
KriyaBio offers drug delivery solutions built around its proprietary permeation enhancer KB01. Their drug delivery technology is based on our patent-pending drug permeation enhancer KB01. KB01 is a smart tight junction modulator capable of facilitating enhanced absorption of co-administered therapies.
Illuminate Health App is a home health technology company. They offer advanced technology that allows them to perform a complete health exam, and encryption ensures data is protected at the highest possible levels.
NUBIX stores and remotely interprets specialty studies connecting specialist with clinics, hospitals, laboratories and public and private cabinets, insurers and patients. We support the diagnosis by managing, storing and interpreting studies of specialty in 3 simple steps: storage of studies, access to studies from anywhere and interpretation of the study at any time. We improve the communication systems available between clinics and hospitals with medical specialists. Our focus is on 3 areas: insurers that seek to reduce their costs based on the reduction of mounted claims, clinics and public and private hospitals that do not have a radiologist or other specialist in their staff, to the public health sector as a third party authorized for distance interpretation and patients who are seeking a second medical opinion about their medical procedures. During its first year of operations (2018) NUBIX serves more than 39,000 patients including more than 35,000 patients for the early detection of breast cancer. Times of up to 25 hours for patient care are achieved through NUBIX compared to other options that take more than a month to perform the interpretation, this is very important since with most types of cancer Breast division takes one to two months, that is, the lesion doubles in size from a treatable finding to a high-risk one.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.